The Zantac Recall
On April 1st, 2020, the US Food and Drug Administration (FDA) formally recalled all Zantac and ranitidine products from the US market because of substantial evidence that the drug contains hazardous levels of the carcinogenic chemical known as N-nitrosodimethylamine, or NDMA.
Tens of thousands of Zantac users who have experienced complications are now coming forward to proceed with legal action. Here at Van Law Firm, our knowledgeable team of Zantac attorneys is currently accepting cases under a personal injury, defective drug, or wrongful death basis.
What You Need to Know
Zantac (ranitidine hydrochloride) is a prescription heartburn and antacid medication that has been approved by the FDA since 1983. One of the most commercially successful drugs of all time, it is available as a daily tablet, an oral solution (syrup), or an injection. It is commonly prescribed for stomach ulcers, acid reflux, and sour stomach.
In recent years, numerous studies have reported astronomical levels of NDMA in Zantac samples– in some cases over 30,000 times the FDA’s daily limit. The reason for this uptick in NDMA generation is the fact that ranitidine (active ingredient in Zantac) is unstable, meaning its compounds degrade and break down over time. The byproducts of this degradation then combine to form NDMA, and the process repeats itself over and over again.
Let us help you!
Dangers of Zantac and NDMA
Health agencies such as the FDA and the World Health Organization (WHO) have classified NDMA as a Group 2A carcinogen, which means that the substance is “probably carcinogenic to humans.” When ingested, NDMA molecules can travel all throughout the bloodstream. As a result, the following cancers have been mentioned in Zantac lawsuits:
- Bladder cancer
- Brain cancer
- Breast cancer
- Esophageal/nasal/throat cancer
- Kidney cancer
- Liver cancer
- Lung cancer (in non-smokers)
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Testicular cancer
- Thyroid cancer
- Uterine cancer
Zantac Lawsuit Eligibility and Criteria
So far, as hundreds of new plaintiffs are added each week, certain guidelines have been established in terms of eligibility. The first half of criteria are based around the parameters of one’s use.
Potential plaintiffs should consider the following:
- You have taken Zantac (or another ranitidine product) on a daily or regular basis for at least 6 months.
- You are a U.S. citizen and used Zantac (ranitidine) in the United States.
- You have used one or more of the following drugs:
Generic ranitidine products
- You did not primarily use Zantac (ranitidine) in Kentucky, Louisiana, Michigan, Tennessee, Puerto Rico, or did not primarily live in any of these places.
- You used Zantac anytime from 2006-onwards– we may not be able to obtain your medical records prior to 2006.
The second half of guidelines pertain to the plaintiff’s health and damages, meaning that he or she must have been diagnosed with one of the types of cancer listed above, and the diagnosis must be attributed to Zantac use. There are certain pre-existing conditions that have been deemed as disqualifying for a Zantac lawsuit– these include hepatitis B and C, H. pylori, and achalasia.
Contact Our Trusted Zantac Lawyers at Van Law Firm
If you or a loved one has a history of Zantac use and also fits the aforementioned criteria including a cancer diagnosis, contact the trusted team of Zantac attorneys at Van Law Firm today.
Call our Nevada office at (702) 529-1011 or our Washington location at (360) 244-4444 to get your case started with a free consultation. Our defective drug and personal injury lawyers have recovered over $50 million in settlements for our clients thus far, and that’s not counting what we can win for you.